ARCUTIS BIOTHERAPEUTIC
10.15
20-9月-24 15:59:59
15 分の遅延
株式
+0.01
+0.10%
本日の幅
9.78 - 10.31
ISIN
N/A
ソース
NASDAQ
-
Arcutis to Present at Upcoming Investor Conference
11 11 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2022 Financial Results and Provides Business Update
08 11 2022 16:02:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter Financial Results
25 10 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Nationwide Seborrheic Dermatitis Survey Shows Burdensome and Lengthy Path to Diagnosis
21 10 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 10 2022 16:00:00 提供 Nasdaq GlobeNewswire
-
26 9 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
20 9 2022 11:07:40 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Acquisition of Ducentis BioTherapeutics Ltd.
07 9 2022 17:00:00 提供 Nasdaq GlobeNewswire
-
06 9 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 9 2022 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Appointment of Neha Krishnamohan to Board of Directors
02 9 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
01 9 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
23 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
22 8 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
10 8 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Second Quarter 2022 Financial Results and Provides Business Update
04 8 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
04 8 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 8 2022 17:55:54 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Announces Pricing of Public Offering of Common Stock
02 8 2022 21:26:57 提供 Nasdaq GlobeNewswire